discovered that CXCL9, and intersectin 2 (ITSN2) in BC tissues were significantly associated with prolonged DFS in 70 patients with cyclophosphamide, methotrexate, and 5‐fluorouracile (CMF)‐chemotherapy. This evidence concerns the gene CXCL9 and breast cancer.